Bionity.COM Newsletter No. 08/2010, 03/03/2010

News about Chemie.DE

Chemie.DE at analytica 2010
From March 23 to March 26, 2010 Chemie.DE is going to be at your disposal at the analytica trade show in Munich. We are looking forward to your visit in Hall A2, Booth 300.

New Products and Services

> more

Innovative MilliPROBE solution von Millipore will cut mycoplasma detection time from 28 days to four hours
The MilliPROBE Detection System for Mycoplasma is the first solution of its kind for the early detection of mycoplasma contamination and enables biopharmaceutical manufacturers to reduce financial risks and optimize product yields...

http://www.bionity.com/products/e/113530/

Request information

SFR Shake Flask Reader - Oxygen and pH Measurement in Shake Flasks
The SFR measures oxygen and pH in up to 9 shake flasks simultaneously and ensures optimal growth conditions for microbial cultivation and cell cultures. The wireless system monitors on-line and non-invasively...

http://www.bionity.com/products/e/107545/

Request information

A world of flexibility: BIOS ANALYTIQUE Rental Solutions
European Partner of Agilent Technologies
Get the instrument you need without waiting for an investment budget! From 1 to 60 months, from one module to a complete system, whether to react on punctual needs or to strategically finance your equipment, you will find the right rental solution with us...

http://www.bionity.com/products/e/86425/

Request information

PCR Diagnostics of Sepsis and Infectious Diseases
Direct pathogen detection from whole blood
The CE-IVD marked, PCR-based sepsis test, SepsiTest^TM, includes all reagents necessary for preparation of DNA from whole blood and pathogen detection. By using broad-range PCR, SepsiTest^TM allows the detection of more than 345 bacterial and fungal pathogens within only 4 hours....

http://www.bionity.com/products/e/105340/

Request information

analytica 2010 | March 23-26| Munich Trade Fair
A gathering for your success!

The international trade fair analytica is the perfect opportunity to gather information about the latest developments and topics of interest in the analysis, laboratory-technology and biotechnology industry.

Approximately 1,000 well-known exhibitors from around the world await you in 5 halls. No other trade fair gives you a market overview that is as comprehensive.
More information:

New vacuum pumping units with electronic control
Vacuum generation in laboratories: Diaphragm pumps are the No. 1 choice among the established vacuum pump technologies thanks to their high chemical resistance, oil-free operation and the possibility of solvent recovery (optional)....

http://www.bionity.com/products/e/79229/

Request information

Magnification up to 30,000x on a smaller footprint
Next Generation TM3000 Tabletop Microscope from Hitachi
With over 1000 units shipped since the launch of the TM-1000 in 2005, Hitachi's Tabletop microscope technology has established itself in a host of applications and industries worldwide, by simplifying and facilitating observation of the microstructures of material surfaces...

http://www.bionity.com/products/e/66217/

Request information

analytica 2010 - Hall A2, Stand 424

Ritmo 05 - Elegance and simplicity of metering
Absolutely tight metering pumps by positive-controlled valve technology
Ritmo 05 Metering Pumps are high precision Metering Pumps with high value full PTFE design, positive-controlled valve technology and stepping motor drive for variable membrane movement...

http://www.bionity.com/products/e/97067/

Request information

Biotech News

> more

Latest News from Biotechnology and Pharma from 02/24/2010 to 03/02/2010

Regular Analgesic Use Increases Hearing Loss in Men
03/02/2010 - In a study published in The American Journal of Medicine, researchers determined that regular use of aspirin, acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) increases the risk of hea...
http://www.bionity.com/news/e/114266/

Merck KGaA to acquire all outstanding Millipore shares for US$ 107 per share in cash
Combination will create a € 2.1 billion (US$ 2.9 billion) partner for the Life Science sector and transform Merck Chemicals
03/02/2010 - Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 p...
http://www.bionity.com/news/e/114330/

BUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet primary endpoint
03/02/2010 - Actelion Ltd announced the initial results of BUILD-3, a clinical study evaluating the safety and efficacy of bosentan in patients suffering from idiopathic pulmonary fibrosis. While there was a cons...
http://www.bionity.com/news/e/114333/

CellCentric Licenses Novel Epigenetic Discovery Programme to Takeda
03/02/2010 - From its broad portfolio of novel targets in epigenetics, CellCentric has out-licensed exclusively the development and commercialisation of an important programme focused on cancer. Under the terms of...
http://www.bionity.com/news/e/114252/

Schizophrenia gene network analysis identifies age-associated defects
03/02/2010 - The underlying causes of the debilitating psychiatric disorder schizophrenia remain poorly understood. In a study published in Genome Research, scientists have performed a powerful gene network analy...
http://www.bionity.com/news/e/114226/

Oriola-KD Corporation completes its Russian acquisition
03/01/2010 - Oriola-KD Corporation has acquired the remaining 25 per cent of the shares in Foreti Oy, which owns the Moscow-based pharmaceutical retail company OOO Vitim and the pharmaceutical wholesale company OO...
http://www.bionity.com/news/e/114107/

Top Pharmaceutical and Biotech companies face slow down in sales growth over 2008–14
03/01/2010 - Top pharmaceutical and biotech companies face a major slow down in sales growth over 2008–14 according to a new report by independent business analyst Datamonitor. The report title "Pharmaceutical Com...
http://www.bionity.com/news/e/114108/

AFFiRiS: Vaccination against hypertension has been awarded an FFG grant up to EUR 1.2 million
03/01/2010 - AFFiRiS AG announced the start of a new program to develop a vaccine against hypertension. This means that there are now four of the company's current seven development projects in the public domain. ...
http://www.bionity.com/news/e/114227/

Data from a post hoc analysis using desmoteplase in ischaemic stroke presented at the International Stroke Conference
03/01/2010 - H. Lundbeck A/S announced that data presented at the International Stroke Conference (ISC) in San Antonio, Texas showed very supportive data for desmoteplase. Post hoc analysis of data from the clinic...
http://www.bionity.com/news/e/114222/

Généthon initiates a new clinical trial for a severe immune deficiency (Wiskott-Aldrich syndrome)
03/01/2010 - Généthon has just obtained approval from the French and British health authorities for a Phase I/II clinical trial of gene therapy for a rare immunodeficiency, Wiskott-Aldrich syndrome (WAS). The Géné...
http://www.bionity.com/news/e/114221/

Aluminum tolerant sorghum
Cloned gene being used to develop aluminum tolerant crops, Kochian says at AAAS
02/26/2010 - Cornell researcher Leon Kochian, in collaboration with Brazilian scientists, has cloned a unique sorghum gene that is being used to develop sorghum lines that can withstand toxic levels of aluminum in...
http://www.bionity.com/news/e/113925/

LEUKOCARE has been granted both ISO 9001 and ISO 13485 certification
02/26/2010 - LEUKOCARE AG, a privately-owned company developing innovative biofunctional surfaces using its proprietary stabilizing postcoating technology, announced that it has successfully established a Quality ...
http://www.bionity.com/news/e/114101/

Cultivation of GM crops increases worldwide, but Europe is missing out
02/26/2010 - More than ever, farmers around the world are turning to GM crops, recognizing the range of benefits that they offer. According to figures released by the International Service for the Acquisition of A...
http://www.bionity.com/news/e/113921/

Pantec Biosolutions reports successful Phase I for delivery of FSH
First time a protein this large has ever been successfully delivered transdermally
02/26/2010 - Pantec Biosolutions AG announced that it has achieved excellent results in a Phase I clinical trial of a FSH (follicle stimulating hormone) patch used in conjunction with the company’s novel P.L.E.A.S...
http://www.bionity.com/news/e/114100/

Basilea announces global partnership with Astellas for its antifungal isavuconazole
02/26/2010 - Basilea announced that Basilea Pharmaceutica International Ltd. has entered into a license, co-development and co-promotion agreement with Astellas Pharma Inc. for Basilea's azole antifungal agent is...
http://www.bionity.com/news/e/114102/

Distinct type of virus found in cancer tissue of HIV-positive patients with lymphoma
02/25/2010 - University of Florida researchers studying samples from HIV-positive patients who died with a type of cancer called non-Hodgkins lymphoma have discovered the existence of two different HIV-1 populatio...
http://www.bionity.com/news/e/113919/

GlycoVaxyn’s First Clinical Study with Bioconjugate Vaccine Initiated
Study to Evaluate Safety, Reactogenicity and Immunogenicity of Vaccine Against Shigella dysenteriae
02/25/2010 - GlycoVaxyn has commenced a Phase I clinical study with its vaccine candidate (GVXN SD133) against Shigella dysenteriae, a cause of serious intestinal infections. This is the first product from the com...
http://www.bionity.com/news/e/113903/

Butalco announces it is to produce its first cellulosic ethanol in summer 2010
02/25/2010 - This summer, Butalco will use its proprietary new yeast technology to produce biofuel from agricultural waste in a pilot plant in Southern Germany. Butalco's new microbial catalysts will enable up to ...
http://www.bionity.com/news/e/113846/

Proteros and Axikin reach significant milestones with integrated drug discovery project
02/25/2010 - Proteros fragments and Axikin Pharmaceuticals Inc. announced the achievement of significant milestones in their integrated drug discovery collaboration.
In January 2010, only nine months after havi...
http://www.bionity.com/news/e/113850/

TopoTarget announces new CEO to prepare commercialisation of belinostat
02/25/2010 - TopoTarget A/S announced that Francois Martelet, MD, takes up the position of CEO of TopoTarget in order to add the necessary late-stage clinical development and marketing expertise to ensure a succes...
http://www.bionity.com/news/e/113901/

Scientists unlock mystery in important photosynthesis step
02/24/2010 - An international team of scientists, including two from Arizona State University, have taken a significant step closer to unlocking the secrets of photosynthesis, and possibly to cleaner fuels. Plants...
http://www.bionity.com/news/e/113803/

Novartis receives FDA approval of Menveo, a vaccine to prevent meningococcal disease
02/24/2010 - Novartis announced that Menveo® (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by the US Fo...
http://www.bionity.com/news/e/113841/

MediGene and Teva sign agreement to commercialize Veregen in Israel
02/24/2010 - MediGene AG has signed a license and supply agreement with Teva Pharmaceutical Industries Ltd. for the supply and commercialization of Veregen(TM) in Israel. Teva will also be responsible for register...
http://www.bionity.com/news/e/113842/

Généthon appoints biopharma industry expert Frédéric Revah as Chief Executive
02/24/2010 - Généthon announced the appointment of Frédéric Revah PhD as Chief Executive. Frédéric Revah brings over 20 years' experience in the pharmaceutical and biotech industries and academic research to the j...
http://www.bionity.com/news/e/113837/

New tool illuminates connections between stem cells and cancer
02/24/2010 - Researchers have a new tool to understand how cancers grow - and with it a new opportunity to identify novel cancer drugs. They've been able to break apart human prostate tissue, extract the stem cell...
http://www.bionity.com/news/e/113804/

Catalogues and Brochures

> more

Santa Cruz 2010 Catalogue | Proteomics Research Products
Over 49,380 well characterized primary antibodies (16450 monoclonal and 32,930 polyclonal antibodies); siRNA, shRNA Plasmid and lentiviral particle gene silencer targeted to all (100%) known human and mouse genes...

http://www.bionity.com/catalogs/e/113878/

Order catalogue

New Tosoh Bioscience GPC Brochure!
The Tosoh Bioscience GPC Brochure gives you a a topical and comprehensive overview about the TSK gel^®polymer GPC columns. In addition to product specifications and ordering information the catalogue includes helpful advice and application data....

http://www.bionity.com/catalogs/e/108937/

Order catalogue

Catalogue by Huber: High precision thermoregulation
Thermodynamics & Microelectronics - "it takes two to tango"
The catalogue shows over 500 thermostats and chillers over the temperature range of -120°C to 425°C. The model variety makes Scale-up easily possible and can be used on applications from research through Kilo and Pilot-Plant and into production...

http://www.bionity.com/catalogs/e/63847/

Order catalogue

Events

> more

Events, Workshops and Training Courses